Colella Samuel D
Director at LAB; 10% owner at INGN; Director at GENOMIC HEALTH INC
- Sold, on record
- $7.4M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Feb 20, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- LABSTANDARD BIOTOOLS INC.Director
- INGNInogen Inc10% owner
- GENOMIC HEALTH INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GENOMIC HEALTH INC197,930 shares
- LAB76,532 shares
- INGN12,035 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GENOMIC HEALTH INCUnusualMar 3 2011
Sold 34,320 shares at $25.45 ($873k)
Colella Samuel D, Director
Sold 47.8% of holdings ($1.8M position)37,552 shares leftFiling
- 2 Form 4 sale GENOMIC HEALTH INCUnusualMay 18 +442 days
Sold 26,294 shares at $33.03 ($868k)
Colella Samuel D, Director
Sold 56.6% of holdings ($1.5M position)20,202 shares leftFiling
- 3 Form 4 sale GENOMIC HEALTH INCUnusualNov 20 +186 days
Sold 30,616 shares at $26.89 ($823k)
Colella Samuel D, Director
Sold 100% of holdings ($823k position)0 shares leftFiling
- 4 Form 4 sale LABUnusualAug 14 +267 days
Sold 23,192 shares at $19.91 ($462k)
Colella Samuel D, Director
Sold 40.1% of holdings ($1.2M position)34,585 shares leftFirst sale on recordFiling
- 5 Form 4 sale INGNPlan not statedSep 9 +391 days
Sold 7,388 shares at $23.25 ($172k)
Colella Samuel D, 10% owner
Sold 10.5% of holdings ($1.6M position)62,733 shares leftFirst sale on recordFiling
- 6 Form 4 sale INGNUnusualOct 24 +45 days
Sold 4,647 shares at $20.76 ($96k)
Colella Samuel D, 10% owner
Sold 100% of holdings ($96k position)0 shares leftFiling
- 7 Form 4 sale LABUnusualFeb 18 +117 days
Sold 8,800 shares at $38.71 ($341k)
Colella Samuel D, Director
Sold 30.9% of holdings ($1.1M position)19,673 shares leftFiling
- 8 Form 4 sale LABUnusualFeb 20 +2 days
Sold 44,540 shares at $38.96 ($1.7M)
Colella Samuel D, Director
Sold 69.4% of holdings ($2.5M position)19,673 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2015 | LAB | Director | Form 4 sale | 44,540 | $1.7M | 69.4% | Unusual | SEC |
| Feb 18, 2015 | LAB | Director | Form 4 sale | 8,800 | $341k | 30.9% | Unusual | SEC |
| Oct 24, 2014 | INGN | 10% owner | Form 4 sale | 4,647 | $96k | 100.0% | Unusual | SEC |
| Sep 9, 2014 | INGN | 10% owner | Form 4 sale | 7,388 | $172k | 10.5% | Plan not stated | SEC |
| Aug 14, 2013 | LAB | Director | Form 4 sale | 23,192 | $462k | 40.1% | Unusual | SEC |
| Nov 20, 2012 | GENOMIC HEALTH INC | Director | Form 4 sale | 30,616 | $823k | 100.0% | Unusual | SEC |
| May 18, 2012 | GENOMIC HEALTH INC | Director | Form 4 sale | 26,294 | $868k | 56.6% | Unusual | SEC |
| Mar 3, 2011 | GENOMIC HEALTH INC | Director | Form 4 sale | 34,320 | $873k | 47.8% | Unusual | SEC |
| Mar 10, 2010 | GENOMIC HEALTH INC | Director | Form 4 sale | 106,700 | $2.1M | 55.6% | Unusual | SEC |